Hepatitis A in Latin America: The current scenario
- Published on 15/04/2025
- Reading time: 6 min.
Viviana E. Ré 1,2, Ezequiel Ridruejo 2,3, Anabella C. Fantilli 1,2, Bruna Damásio Moutinho 4, María Belén Pisano 1,2, Mário Guimarães Pessoa 4
1
Facultad de Ciencias Médicas
Instituto de Virología ‘Dr. J. M. Vanella’
Universidad Nacional de Córdoba
Córdoba
Argentina
2
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)
Buenos Aires
Argentina
3
Department of Medicine. Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno ‘CEMIC’
Hepatology Section
Viral Hepatitits Special Interest Group
Latin American Association for the Study of the Liver (ALEH)
Buenos Aires
Argentina
4
Department of Gastroenterology
Division of Clinical Gastroenterology and Hepatology
University of São Paulo School of Medicine
São Paulo
Brazil
Abstract
This review aims to gather and disseminate updated information regarding hepatitis A virus (HAV) in Latin America (LA) in the last 11 years, including seroprevalence, post‐vaccination studies, virus detection in aqueous matrices and food samples, and outbreak reports. Only 24 seroprevalence studies were published between 2012 and 2023 with 55%–100% reported prevalences of anti‐HAV IgG. Among the 25 LA countries, only eight of them have introduced HAV vaccines...
To continue reading this article in Full-Text...
Search | Advanced search
Articles by topics
